LSTA

Companies
NASDAQ
Lisata Therapeutics Inc.
Health Care
Price Chart
Overview

About LSTA

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Market Cap
$27.1M
Volume
49.2K
Avg. Volume
36.0K
P/E Ratio
-1.0436509
Dividend Yield
0.00%
Employees
26.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.58
Low Correlation
Volatility
High (0.74)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for LSTA.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, LSTA shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$27.1M
Volume49.2K
P/E Ratio-1.04
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how LSTA fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025